Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355622
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2023-02-27
Brief Title:
Prevalence and Characterization of Pain in RASopathies
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Overview
Official Title:
Pain in RASopathies New Investigative Techniques and Possible Treatments
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
3717
Brief Summary:
RASopathies are a group of syndromes caused by variants in genes belonging to the RASMAPK pathway Pain is a neglected topic in RASopathies but it is frequently complained by affected individuals
Detailed Description:
To detect prevalence and characteristics of pain in RASopathies by using scales questionnaires biochemical analysis and neurophysiological assessment tests
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None